Episteme Home

Q: What is Episteme Home's official website?

Episteme Home's official website is www.epistemepharma.com

Q: What is Episteme Home's Revenue?

Episteme Home's revenue is <$5 Million

Q: How many employees does Episteme Home have?

Episteme Home has 11-50 employees

Q: What industry does Episteme Home belong to?

Episteme Home is in the industry of: Business Services , Project Management

Q: How do I contact Episteme Home?

Episteme Home contact info: Phone number: +91 9773478695 Website: www.epistemepharma.com

Q: What does Episteme Home do?

Episteme Home is a consultancy specializing in regulatory affairs for the pharmaceutical industry, offering services such as regulatory strategy building, dossier submission, life cycle management, and regulatory operations. The company aims to support pharmaceutical clients in navigating complex regulatory environments and achieving timely product... approvals. With a team of experienced professionals, Episteme provides tailored solutions to mitigate regulatory risks and ensure compliance throughout the product development process. Their expertise encompasses a wide range of complex dosage forms, making them a reliable partner for clients seeking comprehensive regulatory support. Read More

Q: Is Episteme Home a public company?

Episteme Home is private company therefore does not currently have an official ticker symbol

Business Services · India · 11-50 Employees

View Company Info for Free

Overview

Headquarters

Nilamber Triumph Nilamber Circle 30 Mtr ...

Phone Number

+91 9773478695

Website

www.epistemepharma.com

Revenue

<$5 Million

Industry

Business Services

Project Management

ZI Rank: 1

Signal Type

Mar

Apr

May

Jun

Jul

Aug

ZI Rank

About Episteme Home

Episteme Home is a consultancy specializing in regulatory affairs for the pharmaceutical industry, offering services such as regulatory strategy building, dossier submission, life cycle management, and regulatory operations. The company aims to support pharmaceutical clients in navigating complex regulatory environments and achieving timely product approvals. With a team of experienced professionals, Episteme provides tailored solutions to mitigate regulatory risks and ensure compliance throughout the product development process. Their expertise encompasses a wide range of complex dosage forms, making them a reliable partner for clients seeking comprehensive regulatory support.Explore more

Is this data correct?

View contact profiles from Episteme Home

Popular SearchesEpisteme HomeSIC Code 87,874NAICS Code 54,541Show more

Episteme Home Org Chart

Nayna Daptardar

Founder & Chief Executive Officer

Phone

Prashant Vagadia

Co-Founder & Director

Phone

Get the full picture

Is Episteme Home your ideal customer?

Let us give you the heads up on whether it's a good time to reach out

Last 7 days

Check if Episteme Home has recently received funding, and reach out quickly before it becomes old news!

Product Launch: Get notified when Episteme Home launches new products

Website visits: Recent activity has been detected on your website

Episteme Home, which may be a good buyer, showed buying intent in Masked Content Topic

Congratulate Masked Content for being promoted to Masked Content at Episteme Home

Competitive Alert! Recent activity has been detected by your competitor Masked Content

Earning: See what the market has to say on Episteme Home recently announced quarterly report

Click to see if Episteme Home had a recent Job posting/layoffs

Funding: Get notified immidiatlly once Episteme Home has new funding data

Check out if Episteme Home is spiking on competitors!

Recommended Actions

Find VP level buyers at Episteme Home

Find 2 more new buyers

View Email Formats for Episteme Home

Among all Business Services companies

Low Activity

High Activity

Activity Insights

Episteme Home is experiencing very low activity levels compared to other companies in the Business Services sector.

What does this means?

Episteme Home is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about Episteme Home.